Physician

Alan Lawrence Aarons, M.D.

According to 2025 Medicare claims, Alan Aarons, M.D. (NPI: 1578560363) practices allergy/immunology in the Raleigh-Cary, NC market, with the plurality of this provider's patient population coming from Wake, NC. This provider's primary affiliated billing organization is ALLERGY PARTNERS, PLLC (NPI: 1043677669; TIN: 561249571) and primary practice location at 27607-6694. Aarons is affiliated with the CVS ACO (ACO ID: A5407), participating under the MSSP model.

Aarons' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 195 traditional Medicare patients, billed 11,488 HCPCS/CPT codes, and received $292,195 in Medicare payments. The top billing code was 99203 (New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more). Part D data shows 433 prescription claims across 104 beneficiaries totaling $277,518 in drug costs, led by Dupixent Syringe (Dupilumab). 2021 DME data shows 11 claims. Open Payments data shows 37 records totaling $717. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $29,761 to $292,195. Similarly, Part D prescription costs have moved sharply higher in recent years, from $33,356 to $277,518. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	136	2,391	$29,761
2016	133	4,925	$86,695
2017	124	7,591	$145,788
2018	129	7,559	$144,108
2019	125	7,883	$199,881
2020	136	9,441	$270,698
2021	130	9,075	$283,669
2022	175	8,265	$247,813
2023	171	7,661	$202,531
2024	195	11,488	$292,195

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	53	247	$33,356
2016	62	208	$34,873
2017	67	300	$56,024
2018	75	354	$81,279
2019	91	393	$131,184
2020	90	459	$150,142
2021	105	374	$124,792
2022	102	472	$274,303
2023	97	432	$264,494
2024	104	433	$277,518

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	11	$31
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	50	50	$72
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	42	48	$58
96372	Injection of drug or substance under skin or into muscle	30	142	$9
95117	Professional service for multiple injections of allergen	70	325	$7
95004	Test for allergy using allergenic extract	28	1,050	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Syringe	Dupilumab	35	980	$129,430
Dupixent Pen	Dupilumab	16	448	$62,677
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	1,020	$21,425
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	17	510	$10,665
Breo Ellipta	Fluticasone/Vilanterol	20	600	$7,513

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	37	$717	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

Allergy/immunology providers in the Raleigh-Cary, NC market
Providers within practice ZIP code 27607-6694
Providers whose plurality patient county is Wake, NC
Providers in North Carolina whose primary affiliated billing organization is ALLERGY PARTNERS, PLLC
Providers in North Carolina affiliated with CVS ACO (MSSP)

FAQ

What Medicare data is available for Alan Lawrence Aarons, M.D.?

Tedicare shows public-source Medicare data for Alan Lawrence Aarons, M.D. (NPI 1578560363), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alan Lawrence Aarons, M.D. have ACO affiliation data?

Alan Lawrence Aarons, M.D. is shown with ACO affiliation data for CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to Alan Lawrence Aarons, M.D.?

Alan Lawrence Aarons, M.D. is linked to ALLERGY PARTNERS, PLLC (billing NPI 1043677669) in the available physician profile data.

Does Alan Lawrence Aarons, M.D. have Open Payments data?

Alan Lawrence Aarons, M.D. has 37 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.